Epidemiology and Long-term Outcome of Patients With VHD

Completed

• Conditions: Mitral Insufficiency and Aortic Stenosis; Valvular Heart Disease; Aortic Valve Stenosis; Coronary Artery Disease; Valvular Disease; Mitral Stenosis; Chronic Kidney Diseases
• Interventions: Procedure: Innovative medical technologies in invasive cardiology and cardiac surgery

• Registration Number: NCT04527367
• Lead Sponsor: Medical University of Bialystok

Brief Summary

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. The aim of the study is analysis the epidemiology and the long-term prognosis among patients with VHD.

Detailed Description

Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy.

Patients with moderate and severe valvular heart diseases are included into the study. The set of variables subject to interpretation consisted of demographic data, medical history, result of coronary angiography, and type of applied percutaneous and surgical treatment

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2020-08-22
• Study First Submitted QC: 2020-08-25
• Study First Posted: 2020-08-26
• Status Verified: 2021-12
• Primary Completion: 2022-01
• Study Completion: 2022-01
• Last Update Submitted: 2022-01-06
• Last Update Posted: 2022-01-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

• Valvular heart disease in moderate and severe stages

Exclusion Criteria

• Age < 18 years old

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
VHD patients	Innovative medical technologies in invasive cardiology and cardiac surgery	Patients with moderate and severe valvular heart diseases

Primary Outcome Measures

Name	Time	Method
Death	3665 days	All-cause of mortality

Secondary Outcome Measures

Name	Time	Method
MACCE	3665 days	Mocardial infarction, stent thrombosis, stroke or transient ischemic attack, urgent revascularization

Trial Locations

Locations (1)

Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital; 🇵🇱 Białystok, Poland